Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens

Immunology and Cell Biology

Volumn 92, Issue 5, 2014, Pages 417-426

  Armitage, Charles W ^a   O'meara, Connor P ^a   Harvie, Marina C G ^a   Timms, Peter ^a   Blumberg, Richard S ^b   Beagley, Kenneth W ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chlamydia; FcRn; IgG; vaccine

Indexed keywords

BACTERIAL ANTIGEN; CELL ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; BACTERIAL PROTEIN; BACTERIAL VACCINE; INCLUSION MEMBRANE PROTEIN A; MAJOR OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL LOAD; CHLAMYDIA; CHLAMYDIASIS; FEMALE; IMMUNIZATION; INTRACELLULAR BACTERIUM; LYSOSOME; MALE; NONHUMAN; OPSONIZATION; PATHOGEN CLEARANCE; PH; TRANSCYTOSIS; UTERINE TUBE OCCLUSION; CONTROLLED STUDY; MOUSE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN TARGETING; TESTIS DISEASE; VACCINATION; ANIMAL; CELL LINE; CHLAMYDIA MURIDARUM; DISEASE MODEL; EXTRACELLULAR SPACE; GENE SILENCING; GENETICS; IMMUNOLOGY; INTRACELLULAR SPACE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT;

CHLAMYDIA; CHLAMYDIA MURIDARUM; MUS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; FEMALE; GENE SILENCING; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN G; INTRACELLULAR SPACE; MALE; MICE; MICE, KNOCKOUT; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, FC; TRANSCYTOSIS;

EID: 84901684735     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.110     Document Type: Article

References (54)

1. WHO. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. In Research, RHa, 2012
2. Stamm WE. Chlamydia trachomatis infections: Progress and problems. J Infect Dis 1999; 179(Suppl 2): S380-S383
3. Land JA, Van Bergen JE, Morre SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 2010; 16: 189-204
4. Cunningham KA, Beagley KW. Male genital tract chlamydial infection: Implications for pathology and infertility. Biol Reprod 2008; 79: 180-189
5. Brunham RC, Rey-Ladino J. Immunology of Chlamydia Infection: Implications for a Chlamydia trachomatis Vaccine. Nat Rev Immunol 2005; 5: 149-161. (Pubitemid 40208904
6. Yule TD, Tung KS. Experimental autoimmune orchitis induced by testis and sperm antigen-specific T cell clones: An important pathogenic cytokine is tumor necrosis factor. Endocrinology 1993; 133: 1098-1107. (Pubitemid 23267760
7. Carey AJ, Cunningham KA, Hafner LM, Timms P, Beagley KW. Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice. Immunol Cell Biol 2009; 87: 337-343
8. O'Meara CP, Andrew DW, Beagley KW. The mouse model of Chlamydia genital tract infection: A review of infection, disease, immunity and vaccine development. Curr Mol Med 2013; 8: 8
9. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981; 31: 1161-1176. (Pubitemid 11155484
10. Li Z, Chen C, Chen D, Wu Y, Zhong Y, Zhong G. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 2008; 76: 2746-2757
11. Williams DM, Schachter J, Weiner MH, Grubbs B. Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun 1984; 45: 674-678. (Pubitemid 14066183
12. Morrison SG, Morrison RP. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 2005; 175: 7536-7542. (Pubitemid 41713452
13. Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, Eko FO et al. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 2002; 105: 213-221. (Pubitemid 34146688
14. Scidmore MA, Rockey DD, Fischer ER, Heinzen RA, Hackstadt T. Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect Immun 1996; 64: 5366-5372
15. Su H, Spangrude GJ, Caldwell HD. Expression of Fc gamma RIII on HeLa 229 cells: Possible effect on in vitro neutralization of Chlamydia trachomatis. Infect Immun 1991; 59: 3811-3814
16. Roopenian DC, Akilesh S. FcRn: The neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7: 715-725. (Pubitemid 47327396
17. Claypool SM, Dickinson BL, Yoshida M, Lencer WI, Blumberg RS. Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires coexpressed human beta 2-microglobulin. J Biol Chem 2002; 277: 28038-28050. (Pubitemid 34966755
18. Kim J, Bronson CL, Wani MA, Oberyszyn TM, Mohanty S, Chaudhury C et al. Beta 2-microglobulin Deficient mice catabolize IgG more rapidly than FcRn- alpha-chain Deficient mice. Exp Biol Med (Maywood) 2008; 233: 603-609. (Pubitemid 351657361
19. Knee RA, Hickey DK, Beagley KW, Jones RC. Transport of IgG across the blood-luminal barrier of the male reproductive tract of the rat and the effect of estradiol administration on reabsorption of fluid and IgG by the epididymal ducts. Biol Reprod 2005; 73: 688-694. (Pubitemid 41356127
20. Li Z, Palaniyandi S, Zeng R, Tuo W, Roopenian DC, Zhu X. From the Cover: Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci USA 2011; 108: 4388-4393
21. Yoshida M, Claypool SM, Wagner JS, Mizoguchi E, Mizoguchi A, Roopenian DC et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004; 20: 769-783. (Pubitemid 38757446
22. Bai Y, Ye L, Tesar DB, Song H, Zhao D, Bjorkman PJ et al. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci USA 2011; 108: 18406-18411
23. Levine N, Kelly H. Measurement of pH in the rat epididymis in vivo. J Reprod Fertil 1978; 52: 333-335. (Pubitemid 8277389
24. McCarthy KM, Yoong Y, Simister NE. Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: A system to study protein transport across epithelia. J Cell Sci 2000; 113(Pt 7), 1277-1285. (Pubitemid 30229544
25. Chi EY, Kuo CC, Grayston JT. Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol 1987; 169: 3757-3763. (Pubitemid 17160324
26. Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1999; 1: 119-130
27. Cunningham KA, Carey AJ, Finnie JM, Bao S, Coon C, Jones R et al. Polyimmunoglobulin receptor-mediated transport of IgA into the male genital tract is important for clearance of Chlamydia muridarum infection. Am J Reprod Immunol 2008; 60: 405-414
28. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1996; 93: 5512-5516
29. Lu C, Zeng H, Li Z, Lei L, Yeh IT, Wu Y et al. Protective immunity against mouse upper genital tract pathology correlates with high IFNgamma but low IL-17T cell and antisecretion protein antibody responses induced by replicating chlamydial organisms in the airway. Vaccine 2012; 30: 475-485
30. Zhu X, Meng G, Dickinson BL, Li X, Mizoguchi E, Miao L et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 2001; 166: 3266-3276. (Pubitemid 33117326
31. Ober RJ, Radu CG, Ghetie V, Ward ES. Differences in promiscuity for antibody-FcRn interactions across species: Implications for therapeutic antibodies. Int Immunol 2001; 13: 1551-1559. (Pubitemid 33133882
32. Gastinel LN, Simister NE, Bjorkman PJ. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc Natl Acad Sci USA 1992; 89: 638-642
33. Vidarsson G, Stemerding AM, Stapleton NM, Spliethoff SE, Janssen H, Rebers FE et al. FcRn: An IgG receptor on phagocytes with a novel role in phagocytosis. Blood 2006; 108: 3573-3579
34. Baker K, Qiao SW, Kuo TT, Aveson VG, Platzer B, Andersen JT et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b dendritic cells. Proc Natl Acad Sci USA 2011; 108: 9927-9932
35. Manam S, Nicholson BJ, Murthy AK. OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection. Pathog Dis 2013; 67: 221-224
36. Cunningham KA, Carey AJ, Timms P, Beagley KW. CD4 T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice. Vaccine 2010; 28: 4861-4863
37. Cunningham KA, Carey AJ, Hafner L, Timms P, Beagley KW. Chlamydia muridarum major outer membrane protein-specific antibodies inhibit in vitro infection but enhance pathology in vivo. Am J Reprod Immunol 2010; 4: 118-126
38. Cochrane M, Armitage CW, O'Meara CP, Beagley KW. Towards a Chlamydia trachomatis vaccine: How close are we?. Future Microbiol 2010; 5: 1833-1856
39. Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW 3rd, Mestecky J. Urethral cytokine and immune responses in Chlamydia trachomatis-infected males. Infect Immun 2001; 69: 7178-7181. (Pubitemid 32995483
40. Zeng H, Gong S, Hou S, Zou Q, Zhong G. Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum. Infect Immun 2012; 80: 1098-1106
41. Rzomp KA, Scholtes LD, Briggs BJ, Whittaker GR, Scidmore MA. Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect Immun 2003; 71: 5855-5870. (Pubitemid 37205639
42. Fields KA, Hackstadt T. The chlamydial inclusion: Escape from the endocytic pathway. Annu Rev Cell Dev Biol 2002; 18: 221-245. (Pubitemid 35387351
43. Holtta-Vuori M, Tanhuanpaa K, Mobius W, Somerharju P, Ikonen E. Modulation of cellular cholesterol transport and homeostasis by Rab11. Mol Biol Cell 2002; 13: 3107-3122. (Pubitemid 35034249
44. Rzomp KA, Moorhead AR, Scidmore MA. The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun 2006; 74: 5362-5373. (Pubitemid 44300456
45. Ward ES, Martinez C, Vaccaro C, Zhou J, Tang Q, Ober RJ. From sorting endosomes to exocytosis: Association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling. Mol Biol Cell 2005; 16: 2028-2038. (Pubitemid 40471968
46. Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, Hackstadt T. Three temporal classes of gene expression During the Chlamydia trachomatis developmental cycle. Mol Microbiol 2000; 37: 913-925
47. Sipila P, Shariatmadari R, Huhtaniemi IT, Poutanen M. Immortalization of epididymal epithelium in transgenic mice expressing simian virus 40T antigen: Characterization of cell lines and regulation of the polyoma enhancer activator 3. Endocrinology 2004; 145: 437-446. (Pubitemid 38094540
48. Madi A, Svinareff P, Orange N, Feuilloley MG, Connil N. Pseudomonas fluorescens alters epithelial permeability and translocates across Caco-2/TC7 intestinal cells. Gut Pathog 2010; 2: 2-16
49. Claypool SM, Dickinson BL, Wagner JS, Johansen FE, Venu N, Borawski JA et al. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. Mol Biol Cell 2004; 15: 1746-1759. (Pubitemid 38401824
50. Cunningham KA, Carey AJ, Lycke N, Timms P, Beagley KW. CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa. J Reprod Immunol 2009; 81: 34-38
51. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol 1999; 33: 753-765
52. Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T. Chlamydia trachomatis induces remodelling of the actin cytoskeleton During attachment and entry into HeLa cells. Infect Immun 2002; 70: 3793-3803
53. O'Meara CP, Armitage CW, Harvie MC, Timms P, Lycke NY, Beagley KW. Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PLoS One 2013; 8: E61962
54. Pal S, Peterson EM, de la Maza LM. New murine model for the study of chlamydia trachomatis genitourinary tract infections in males. Infect Immun 2004; 72: 4210-4216. (Pubitemid 38821935